S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.21
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.51
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
ORGO · Organogenesis Holdings Inc. Class A
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
Organogenesis Holdings Inc (ORGO)
NASDAQ NMS - GLOBAL MARKET
Biotechnology
$0.99
-0.04
(-3.90%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$0.99
$0.96
$1.05
52-WEEK RANGE
$0.99
$0.93
$7.08
What's happening
- ORGO is down 3.90% today, trading at $0.99. — Live quote
- It's trading within 3% of its 52-week low ($0.93). (Finnhub fundamentals)
- Volume today (45,303) is well below its 3-month average of 788,340. (Finnhub fundamentals)
- Reports earnings on 2026-11-05, 14 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $-0.73 actual vs. $-0.36 estimated (-104.5%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 0
Buy 0
Hold 4
Sell 1
Strong sell 2
Aggregate ratings for 2026-10-01 (7 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
ORGO
-80.31%
vs S&P 500
-93.09%
1-YEAR RETURN
ORGO
-75.00%
vs S&P 500
-89.56%
6-MONTH RETURN
ORGO
-60.00%
3-MONTH RETURN
ORGO
-61.94%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.73
Est. $-0.36
MISS -104.5%
2026-04-26 (Q1 2026)
$-0.41
Est. $-0.32
MISS -29.7%
2026-01-26 (Q4 2025)
$0.31
Est. $0.21
BEAT +44.7%
2025-10-26 (Q3 2025)
$0.15
Est. $0.06
BEAT +167.4%
Valuation Measures & Ratios
Enterprise Value4$91.7M
Forward P/E5—
PEG Ratio6-0.00
Price / Sales (TTM1)0.28
Price / Book71.09
EV4 / Revenue0.20
EV4 / EBITDA4.94
Profit Margin-18.40%
Operating Margin-7.84%
Return on Equity (ROE8)-22.60%
Return on Assets (ROA9)-16.54%
Avg Volume (3M)788,340
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $302.6M | $287.5M | $827.4M | $343.7M | $477.2M |
| P/E | -2.20 | -4.81 | 146.10 | -10.43 | -18.60 |
| Price/Sales | 0.91 | 0.77 | 1.82 | 0.79 | 1.08 |
| Price/Book | 2.04 | 1.18 | 3.24 | 1.47 | 1.96 |
| EV/Revenue | 0.77 | 0.52 | 1.68 | 0.62 | 0.83 |
| EV/EBITDA | -2.67 | -2.72 | 315.03 | — | — |
| ROE | -92.57% | -24.46% | 2.22% | -14.13% | -10.56% |
| ROA | -33.77% | -11.50% | 1.11% | -7.14% | -5.49% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short15,002,130
Change from Prior Settlement+6.25%
% of Float—
Days to Cover (Short Ratio)26.63
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Latest SEC filing is Form 8-K, filed 2026-08-06; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Revenue growth is -56.7% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is -18.4%. Finnhub fundamentals ↗
- Trailing 52-week price return is -75.0%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on ORGO
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $43.8M | $37.2M | $150.9M | $101.0M | $86.7M | $115.2M | $130.2M | $110.0M |
| Gross profit | — | — | — | — | $63.0M | $88.4M | $101.0M | $81.3M |
| Operating income | -$51.0M | -$68.9M | $20.7M | -$12.6M | -$26.7M | $6.2M | -$13.9M | -$3.9M |
| Net income | -$96.3M | -$53.2M | $21.6M | -$9.4M | -$18.8M | $12.3M | -$17.0M | -$2.1M |
| EPS (diluted) | $-0.77 | $-0.44 | $0.11 | $-0.10 | $-0.17 | $0.09 | $-0.13 | $-0.02 |
| EPS (basic) | $-0.77 | $-0.44 | $0.11 | $-0.10 | $-0.17 | $0.09 | $-0.13 | $-0.02 |
| Operating margin | -$117 | -$185 | $14 | -$12 | -$31 | $5 | -$11 | -$4 |
| Net margin | -$220 | -$143 | $14 | -$9 | -$22 | $11 | -$13 | -$2 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $406.4M | $520.0M | $598.7M | $509.8M | $461.1M | $467.4M | $497.9M | $446.3M |
| Total liabilities | $118.3M | $138.6M | $164.8M | $123.8M | $99.9M | $99.3M | $112.6M | $167.7M |
| Stockholders' equity | $148.3M | $244.6M | $300.1M | $255.1M | $233.2M | $242.9M | $262.9M | $278.5M |
| Total current assets | $200.3M | $268.5M | $362.2M | $299.7M | $260.2M | $268.2M | $285.9M | $238.5M |
| Total current liabilities | $57.0M | $76.0M | $100.1M | $90.3M | $65.8M | $65.1M | $77.5M | $77.3M |
| Cash & equivalents | $46.1M | $91.4M | $93.7M | $63.7M | $73.1M | $110.0M | $135.6M | $94.3M |
| Accounts receivable | $100.9M | $116.9M | $217.5M | $168.8M | $120.4M | $103.3M | $109.9M | $101.3M |
| Inventory | $29.3M | $28.4M | $29.6M | $39.6M | $33.0M | $29.3M | $26.2M | $27.0M |
| Property, plant & equipment | $101.5M | $104.1M | $103.7M | $78.1M | $75.6M | $75.5M | $89.1M | $89.9M |
| Goodwill | $28.8M | $28.8M | $28.8M | $28.8M | $28.8M | $28.8M | $28.8M | $28.8M |
| Intangible assets | $3.0M | $3.4M | $9.1M | $9.9M | $10.8M | $11.6M | $12.5M | $13.3M |
| Other non-current assets | $22.9M | $16.1M | $9.2M | $14.4M | $8.7M | $5.8M | $5.0M | $5.0M |
| Accounts payable | $29.3M | $28.6M | $31.9M | $40.2M | $29.7M | $24.7M | $28.9M | $24.0M |
| Accrued liabilities | — | — | $49.5M | $40.3M | $26.3M | $31.1M | $39.5M | $36.1M |
| Long-term debt | — | — | — | — | — | — | — | $62.3M |
| Other non-current liabilities | $3.7M | $1.5M | $1.2M | $2.5M | $3.0M | $897.0K | $894.0K | $1.3M |
| Common stock & paid-in capital | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K |
| Retained earnings | -$152.5M | -$56.2M | -$3.1M | -$46.8M | -$68.3M | -$59.0M | -$40.1M | -$47.8M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$31.7M | $21.1M | $39.4M | $3.1M | -$32.9M | -$19.9M | $10.9M | $8.7M |
| Investing cash flow | -$1.1M | -$3.1M | -$4.7M | -$2.2M | -$3.6M | -$3.6M | -$3.4M | -$2.6M |
| Financing cash flow | -$12.5M | -$20.2M | -$4.8M | -$10.2M | -$288.0K | -$2.1M | $33.6M | -$1.7M |
| Free cash flow | -$32.8M | $18.0M | $34.8M | $844.0K | -$36.5M | -$23.6M | $7.6M | $6.1M |
| Capital expenditures | $1.1M | $3.1M | $4.7M | $2.2M | $3.6M | $3.6M | $3.4M | $2.6M |
| Depreciation & amortization | $3.7M | $4.2M | $4.1M | $4.0M | $3.7M | $3.4M | $3.6M | $3.6M |
| Share-based compensation | $3.1M | $3.6M | $4.3M | $3.1M | $2.5M | $3.4M | $2.9M | $2.7M |
| Deferred income taxes | $45.3M | -$15.4M | $15.6M | -$3.8M | -$1.0M | -$1.3M | -$2.8M | -$2.2M |
| Change in accounts receivable | -$15.0M | -$104.5M | $51.5M | $50.7M | $19.3M | -$5.7M | $8.8M | -$3.0M |
| Change in inventory | $3.1M | $8.7M | $3.0M | -$938.0K | $7.2M | $8.7M | $455.0K | $3.7M |
| Change in accounts payable | $605.0K | -$2.0M | -$1.2M | -$994.0K | $4.1M | -$2.5M | $3.6M | -$3.9M |
| Share repurchases | — | — | — | — | — | — | $25.5M | — |
| Tax withholding on stock comp | $0 | $3.1M | $87.0K | $2.0K | $0 | $1.8M | $2.0K | -$1.0K |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $564.2M | $482.0M | $433.1M | $450.9M | $467.4M |
| Gross profit | — | $366.3M | $326.7M | $345.9M | $353.2M |
| Operating income | $44.7M | -$1.3M | $12.5M | $22.3M | $72.2M |
| Net income | $37.0M | $861.0K | $4.9M | $15.5M | $94.2M |
| EPS (diluted) | $0.15 | $-0.01 | $0.04 | $0.12 | $0.70 |
| EPS (basic) | $0.16 | $-0.01 | $0.04 | $0.12 | $0.73 |
| Operating margin | $8 | -$0 | $3 | $5 | $15 |
| Net margin | $7 | $0 | $1 | $3 | $20 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Mar '22 |
|---|---|---|---|---|---|
| Total assets | $598.7M | $497.9M | $460.0M | $449.4M | — |
| Total liabilities | $164.8M | $112.6M | $181.4M | $183.7M | $194.7M |
| Stockholders' equity | $300.1M | $262.9M | $278.7M | $265.7M | $241.5M |
| Total current assets | $362.2M | $285.9M | $225.0M | $222.6M | — |
| Total current liabilities | $100.1M | $77.5M | $80.5M | $75.0M | $78.5M |
| Cash & equivalents | $93.7M | $135.6M | $103.8M | $102.5M | — |
| Accounts receivable | $217.5M | $109.9M | $82.0M | $89.5M | — |
| Inventory | $29.6M | $26.2M | $28.3M | $24.8M | — |
| Property, plant & equipment | $103.7M | $89.1M | $116.2M | $102.5M | — |
| Goodwill | $28.8M | $28.8M | $28.8M | $28.8M | — |
| Intangible assets | $9.1M | $12.5M | $15.9M | $20.8M | — |
| Other non-current assets | $9.2M | $5.0M | $6.0M | $1.5M | — |
| Accounts payable | $31.9M | $28.9M | $30.7M | $32.3M | — |
| Accrued liabilities | $49.5M | $39.5M | $30.1M | $26.4M | — |
| Long-term debt | — | — | $66.6M | $71.2M | — |
| Other non-current liabilities | $1.2M | $894.0K | $1.2M | $1.1M | — |
| Common stock & paid-in capital | $13.0K | $13.0K | $13.0K | $13.0K | — |
| Retained earnings | -$3.1M | -$40.1M | -$41.0M | -$45.3M | -$61.7M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$10.3M | $14.2M | $30.9M | $24.9M | $62.0M |
| Investing cash flow | -$14.2M | -$10.0M | -$24.4M | -$33.9M | -$31.2M |
| Financing cash flow | -$17.4M | $27.6M | -$5.5M | -$2.2M | -$1.0M |
| Free cash flow | -$24.5M | $4.2M | $6.6M | -$9.0M | $30.8M |
| Capital expenditures | $14.2M | $10.0M | $24.4M | $33.9M | $31.2M |
| Depreciation & amortization | $15.3M | $13.6M | $10.4M | $5.8M | — |
| Share-based compensation | $13.3M | $10.6M | $9.0M | $6.6M | $3.9M |
| Deferred income taxes | $9.5M | -$10.7M | $2.0M | $2.0M | -$32.0M |
| Change in accounts receivable | $115.8M | $31.8M | -$5.5M | $8.8M | $28.7M |
| Change in inventory | $17.9M | $6.2M | $8.2M | $9.4M | $9.3M |
| Change in accounts payable | -$528.0K | -$2.4M | -$108.0K | $3.3M | $3.8M |
| Share repurchases | — | $25.5M | $0 | $0 | — |
| Tax withholding on stock comp | $1.9M | $1.2M | $332.0K | $648.0K | $737.0K |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding ORGO as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Insider activity is not available for this symbol right now.
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 01:26 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-08-06 | 8-K | 2026-08-06 | View on SEC.gov → |
| 2026-08-06 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-06 | 8-K | 2026-08-06 | View on SEC.gov → |
| 2026-06-16 | 8-K | 2026-06-15 | View on SEC.gov → |
| 2026-05-07 | 10-Q | 2026-03-31 | View on SEC.gov → |
| 2026-05-07 | 8-K | 2026-05-07 | View on SEC.gov → |
| 2026-04-24 | 4 | 2025-01-10 | View on SEC.gov → |
| 2026-03-11 | 4 | 2026-03-09 | View on SEC.gov → |
| 2026-03-11 | 4 | 2026-03-09 | View on SEC.gov → |
| 2026-03-03 | 4 | 2026-03-01 | View on SEC.gov → |
| 2026-02-26 | 10-K | 2025-12-31 | View on SEC.gov → |
| 2026-02-26 | 8-K | 2026-02-26 | View on SEC.gov → |
Recent news
Headlines about ORGO (Organogenesis Holdings Inc. Class A). Links open the publisher — we don’t host full articles.
-
JCI,STX,KDP,ABX,FLEX,ROIV,APEI,ORGO | Stock Prices | Quote Comparison
Yahoo! Finance Canada · 2026-10-21 -
ORGO Nov 2026 2.500 call (ORGO261120C00002500) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-18 -
ELYS,TYG,SVRA,BTTX,GLSI,EMMA,ORGO,KBNT,EVER | Stock Prices | Quote Comparison
Yahoo! Finance Canada · 2026-10-16 -
Organogenesis Announces Publication of Peer-Reviewed PREPARE Trial Results Demonstrating Clinical Benefit of PuraPly®AM for Hard-to-Heal Diabetic Foot Ulcers
Yahoo · 2026-10-12 -
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2026 Financial Results on November 5, 2026
Yahoo · 2026-10-12 -
Organogenesis Holdings Announces Publication Of Results From PREPARE, Multicenter, RCT Evaluating PuraPlyAM Plus SoC Compared To SoC Alone In Hard-To-Heal Diabetic Foot Ulcers
Benzinga · 2026-10-12 -
Organogenesis (ORGO) Q2 2026 Earnings Call Transcript
Yahoo Finance · 2026-08-13 -
Organogenesis Holdings (ORGO) Stock Fair Value Moves Lower After Guidance Cut And Analyst Caution
Yahoo Finance · 2026-08-10
No headlines in this category right now — try “All”.